The basic helix-loop-helix transcription factor, Mash2, has been shown to be necessary for the development of the spongiotrophoblast of the mature chorioallantoic placenta of the mouse. Here we show that Mash2 is transcribed during oogenesis and expressed throughout preimplantation development, only becoming restricted to the diploid trophoblast around the time of implantation. This expression raised the possibility that Mash2 has earlier functions in the trophoblast lineage that were not detectable in mutant embryos because of the persistence of oogenetically derived protein. This was tested by generating viable Mash2 − / − females by tetraploid rescue of the extraembryonic defect. Mutant embryos derived from such females showed no enhanced phenotype over embryos produced from heterozygous females, demonstrating unequivocally that neither maternal nor zygotic Mash2 is required for early trophoblast development. If Mash2 functions in other aspects of trophoblast development, it must act cooperatively with other factors.
Introduction
The trophoblast cell lineage is the first cell lineage to differentiate in the early mammalian embryo and it is critical for the survival of the embryo in the uterine environment. Lineage analysis in reconstituted mouse blastocysts (Gardner et al., 1973; Papaioannou, 1982; Rossant et al., 1983) has shown that the trophectoderm layer of the blastocyst gives rise to the primary and secondary giant cells, ectoplacental cone and extraembryonic ectoderm of the early postimplantation stages and later to the giant cells, spongiotrophoblast and labyrinthine layers of the mature chorioallantoic placenta (Rossant and Croy, 1985) . Correct interaction between trophoblast and uterine epithelium is an essential component of the implantation process and normal development of the later trophoblast constituents of the placenta is necessary to allow interchange of nutrients and metabolites between the fetus and the mother. Trophoblast cells are also important sources of pregnancy-associated hormones (Soares et al., 1996) and play a role in immune protection of the fetus (Billington, 1993; Guilbert et al., 1993) .
There is considerable information at the cell biological level about the processes initiating the formation of the trophoblast cell lineage at the blastocyst stage (Fleming and Johnson, 1988) and about the later derivatives of the trophectoderm and their functions (Cross et al., 1994) . However, until recently there was little information on the molecular basis of establishment and maintenance of the trophoblast. Recent targeted mutagenesis experiments have implicated several different genes in aspects of trophoblast development, including signaling molecules and their receptors Miettinen et al., 1995; Schmidt et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995; Uehara et al., 1995; Maina et al., 1996; Monkley et al., 1996) as well as cell type-specific transcription factors. We have previously shown that Mash2, a member of the bHLH gene family which includes many genes involved in cell type specification, is expressed in diploid trophoblast and is required for normal development of the placenta (Guillemot et al., 1994) . Conceptuses that lack Mash2 protein die by day 10 of development with a highly reduced placenta in which the spongiotrophoblast is specifically depleted. The Mash2 mutant phenotype could be rescued by aggregation with tetraploid embryos, indicating that Mash2 was not required within the embryo itself, but was specifically required for the normal development of at least a subset of trophoblast cells. Although this study demonstrated the importance of Mash2 in the trophoblast lineage, the phenotype was more restricted in time and space than might have been predicted from the expression pattern of the gene.
In this report we describe the detailed expression of Mash2 and show that it is expressed during oogenesis, in all cells of the preimplantation embryo, and only becomes trophoblast-restricted around implantation. Expression is then high in all diploid trophoblast cells until around day 12 of gestation, when expression becomes patchy within the placenta and gradually declines as gestation proceeds. This expression pattern raised the possibility that maternal Mash2 protein could be present and play a role in the initiation of trophoblast development at the blastocyst stage or in the early postimplantation trophoblast lineage. However, we show, by breeding mice obtained by tetraploid rescue, that maternal Mash2 is not required for blastocyst development or implantation. Moreover, a-amanitin treatment of two-cell stage embryos reveals that essentially all maternal Mash2 transcripts are eliminated by the late two-cell stage. Thus, Mash2 function in the embryo is clearly independent of any maternal contribution, follows a pattern of progressive spatial and cell-type retriction in expression around the time of implantation, and is indispensable for formation of the spongiotrophoblast. If Mash2 plays a broader role in initiation or differentiation of trophoblast, it must act in conjunction with other factors.
Results

Postimplantation expression of Mash2
As previously reported, Mash2 transcripts were abundantly expressed in the ectoplacental cone and extraembryonic ectoderm of the day 7.5 conceptus, with expression confined to the diploid trophoblast cell populations. Expression persisted at high levels in all the diploid trophoblast cells of the late 8.5 day placenta, although expression was stronger in the ectoplacental cone than in the chorion layer, which is beginning to be invaded by allantoic cells to form the labyrinthine layer of the mature placenta (Fig. 1A) . At day 9.5-10.5, expression persisted in both the labyr- inthine layer and the outer spongiotrophoblast layer of the placenta, with stronger expression in the spongiotrophoblast (Fig. 1C) . Beyond day 10, expression levels began to decline and were more patchy within the placental layers. By day 12.5, expression was still apparent in the spongiotrophoblast and patchy in the labyrinthine layer (Fig. 1E) but by day 15.5, expression of Mash2 had declined markedly and, by day 18.5 was barely detectable (not shown).
When expression of Mash2 was examined at earlier postimplantation stages, it was abundant and specific to the trophoblast from the time of implantation. Early egg cylinder stage embryos showed strong Mash2 expression throughout the diploid ectoplacental cone and the extraembryonic ectoderm, but no expression in the giant cells or the embryonic ectoderm or primitive endoderm (Fig. 2C) .
Expression of Mash2 during preimplantation development
To determine when and where Mash2 transcripts are first detectable during development, quantitative PCR analysis was performed on embryos from zygote to blastocyst stage (Fig. 3) . Mash2 transcripts were of low abundance as a proportion of total message until the late two-cell stage (49 h). Between the late two-cell stage and the eight-cell stage (77 h), Mash2 mRNA increased in abundance only slightly. At the morula stage (88 h), the Mash2 gene appeared to be induced, leading to a nearly 10-fold increase in abundance during development to the blastocyst stage (Fig. 3) .
To determine whether Mash2 is trophectoderm-specific by the blastocyst stage, we performed in situ hybridization on intact blastocysts and reverse transcriptase-polymerase chain reaction (RT-PCR) on isolated inner cell masses (ICMs). In situ hybridization clearly showed expression of Mash2 in cells of the trophectoderm at the early and late blastocyst stage (Fig. 2B ). It also appeared that there could be low level expression of Mash2 in the ICM. To confirm this, we analyzed expression in immunosurgically isolated ICMs at 118 h post-human chotionic gonadotrophin (hCG) using quantitative RT-PCR. Mash2 transcripts were detected in the ICMs (92 + 3 cpm bound) but the relative level of expression was 3-fold less than in whole blastocysts (227 + 3 cpm bound). This suggests that there is already differential expression of Mash2 in the trophectoderm versus the ICM at the blastocyst stage. Complete restriction of Mash2 expression to the diploid trophoblast does not occur until after implantation and must involve downregulation of Mash2 transcription in both the ICM and the mural trophectoderm, since these give rise to the embryo proper and the primary trophoblast giant cells, respectively, neither of RT-PCR analysis was performed as described . The data are expressed as (A) the mean ± SEM of the number of counts per minute (cpm) bound, or (B) the estimated number of copies per embryo for each stage or time indicated. Stages of development (germinal vesicle intact oocyte (GVOOC), egg, one to eight-cell stages, and blastocyst) are indicated above the graph.
which express significant levels of Mash2 after implantation.
The presence of Mash2 mRNA in the one-cell zygote indicated that Mash2 could be expressed as a maternal transcript, since there is very little transcription during the onecell stage (Piko and Clegg, 1982; Latham et al., 1992; Aoki et al., 1997) . In situ hybridization to ovaries revealed the presence of Mash2 transcripts in all stages of oogenesis, from immature oocyte to mature oocytes in the antral follicles, supporting the concept of maternal transcription ( Fig.  2A) . The highest concentration of silver grains was observed in immature oocytes and transcripts appeared to be diluted as the oocytes grow and mature. This is consistent with the known period of active transcription that occurs early in oogenesis (Bachvarova, 1981) . Expression of Mash2 was not observed at any stage in spermatogenesis (data not shown).
a-Amanitin treatment was used to determine the onset of embryonic Mash2 transcription versus persistence of maternal transcript. Mash2 mRNA was abundantly expressed in germinal vesicle-intact oocytes, but decreased in abundance considerably in ovulated eggs, presumably due to degradation of maternal message (Fig. 3) . Treatment of one-and two-cell stage embryos with a-amanitin revealed that aamanitin had only a slight effect on Mash2 mRNA abundance through the mid two-cell stage (Table 1) . At the late two-cell stage (49 h post-hCG injection), a-amanitin treatment almost completely eliminated Mash2 mRNA expression, indicating that by this stage expression is essentially wholly attributable to embryonic transcription. Mash2 mRNA was approximately 2-fold more abundant in the blastocyst stage embryo than in the germinal vesicle stage oocytes. Thus, maternal transcripts of Mash2 are replaced by embryonic transcripts as preimplantation development proceeds.
Effect of imprinting on preimplantation expression of Mash2
These results established that there is both maternal and embryonic transcription of Mash2, and suggested that essentially all of the Mash2 transcripts detected after the two-cell stage of development were derived from embryonic transcription. This analysis could not distinguish whether this transcription was from the maternal or paternal genome or both. This is an important consideration because the Mash2 gene is regulated by genomic imprinting. During later stages of development, expression is restricted to the maternal allele (Guillemot et al., 1995) . Recent studies have shown that some imprinted genes fail to manifest their imprints in the early embryo, with both the maternal and the paternal alleles being expressed, whereas other imprinted genes exhibit significant differences in parental allele expression from their earliest time of expression. In addition, the manifestation of imprinting of a number of genes is subject to tissue-specific as well as stage-specific factors (for review see, Latham, 1995) . Our earlier studies revealed that there is some expression from the paternal Mash2 allele at 6.5 and 7.5 days of gestation in Mash2 heterozygous mutant embryos bearing a single wild-type allele inherited paternally (Guillemot et al., 1995) , suggesting that the paternal allele is not completely silenced by this stage. It was of interest to determine whether imprinting affected the early expression of Mash2 and therefore might affect early steps of trophoblast development.
To address this question, we determined the effect of imprinting on Mash2 expression during preimplantation development. Using the quantitative RT-PCR method, we compared Mash2 mRNA abundance between normal embryos and embryos, derived by nuclear transplantation, that contained two copies of the maternal genome (gynogenotes) or two copies of the paternal genome (androgenotes). We also compared expression in parthenogenetic embryos with that of normal embryos. The analysis of gene expression in such uniparental embryos provides one means for evaluating the effects of imprinting on the expression of parental alleles (Latham et al., 1994 Mann et al., 1995) . The results obtained with uniparental embryos have thus far been confirmed in F1 hybrid embryos obtained from inter-species crosses (e.g. Hatada et al., 1995; Szabo and Mann, 1995) . Data are expressed in units of bound cpm. Gynogenotes and androgenotes both expressed Mash2 at all stages examined (Table 2 ). Very little difference in Mash2 mRNA expression was observed between androgenotes and gynogenotes at the eight-cell stage, indicating that imprinting probably does not affect expression at this early stage. The 2-fold reduction in Mash2 mRNA abundance in both classes of embryos relative to normal embryos may reflect a slight delay in the developmentally programmed increase in Mash2 gene expression in these embryos. At both the morula and blastocyst stages, androgenotes actually expressed more Mash2 mRNA than gynogenotes or parthenotes. This would not be expected if the paternal allele were silenced by imprinting during preimplantation development. This analysis suggests, therefore, that the imprinting of the Mash2 locus is not reflected in differential expression in the preimplantation embryo. Together with our previous observation of continued expression from the paternal allele in early postimplantation development in Mash2 heterozygous mutants, the data suggest that differential expression from the maternal and paternal allele of Mash2 is progressively established after implantation.
Is oogenetically transcribed Mash2 required for normal development?
The expression analysis for Mash2 revealed much wider and earlier expression of Mash2 than might have been predicted from the mutant phenotype. The high abundance of maternal Mash2 transcripts in the oocyte raised the possibility that maternally derived Mash2 protein might persist during cleavage unless subject to specific degradation and consequently contribute to early development of the trophectoderm lineage, either alone or in combination with embryonically encoded Mash2 protein. In our previous mutational analysis of Mash2, mutant phenotypes were assessed in the progeny of Mash2 heterozygous mice. In such a cross, maternal Mash2 transcripts and, presumably, protein will still be present in the oocytes of the heterozygous females, and could obscure any early phenotypic effect.
Viable Mash2 − / − mice were produced by aggregating mutant embryos with tetraploid wild-type embryos. Out of 68 viable offspring derived by aggregating eight-cell embryos from Mash2 heterozygous crosses with tetraploid wild-type embryos, one male and four female Mash2 − / − mice were identified. This is lower than the predicted Mendelian ratio, reflecting the fact that the extraembryonic lineages may contain some initial contribution from Mash2 mutant cells in some cases and thus not allow rescue of the mutant embryo. A complete segregation between the embryo and the extraembryonic lineages in tetraploid aggregates can only be achieved when either inner cell masses or embryonic stem (ES) cells are aggregated with tetraploid embryos (Nagy et al., 1990) . Three Mash2 − / − females were crossed with heterozygous males and the outcomes assessed at various stages of gestation. If Mash2 maternal product is essential for normal development of the early embryo, the prediction would be that all progeny, both wild-type and heterozygous, will die at implantation or before, even though there will be some expression from the paternally imprinted wild-type allele (as shown above) in the heterozygous embryos. If either oogenetically or zygotically derived Mash2 product is sufficient, then the +/− blastocysts might be expected to survive the periimplantation period, while the −/− embryos would die. If maternal Mash2 plays no essential role in early development, all progeny, both +/− and −/−, would be expected to die around day 10.5 of gestation, because the paternal allele is non-functional by this stage. Fifteen embryos were recovered at the blastocyst stage from one Mash2 − / − female and cultured for 4 days on gelatinized tissue culture plates, before PCR genotyping. There were seven Mash2 − / − and 8 Mash2 + / − embryos. No difference in initial blastocyst morphology or in the size and morphology of the trophoblast or ICM outgrowths could be observed between the two genotype groups (not shown). Conceptuses were dissected at day 9.5 from the remaining two females. All were still alive. Again, equal numbers of the two expected genotypes were found (8 −/− and 10+/−), indicating that embryos lacking oogenetically derived Mash2 are able to develop normally through the peri-implantation period. Histological examination of the placentae of both genotypes revealed a similar deficit in the developing spongiotrophoblast layer to that observed in embryos of the same genotypes derived from heterozygous females (Fig. 4 and data not shown). These data clearly show that maternally derived Mash2 product plays no essential role in oogenesis or early mouse development. To totally eliminate a role for any gametederived Mash2, one Mash2 − / − female was crossed with the Mash2 − / − male. The female was killed at day 10.5.
Ten dead embryos were recovered. All showed exactly the same embryo arrest and placental phenotype found in Mash2 − / − embryos derived from heterozygous crosses (not shown).
Discussion
Mash2 is a member of the large family of basic helixloop-helix proteins, and plays a critical role in the specification of postimplantation spongiotrophoblast (Guillemot et al., 1994) . We show here that Mash2 transcripts are detected throughout oogenesis and preimplantation development and in both the ICM and trophectoderm of the early blastocyst, only becoming trophoblast-specific after implantation. Expression of Mash2 mRNA clearly precedes the specification of the trophectoderm lineage at the blastocyst stage (Rossant, 1986) , and only becomes trophoblast-specific at the time when the trophectoderm and ICM lineages become closed (Rossant, 1995) . It is interesting in this regard to note the complementary pattern of expression of the Oct3/4 gene, which has been proposed to be critical for development of the pluripotent ICM lineage. This gene is also expressed throughout the preimplantation embryo and the early blastocyst but becomes ICM-specific at the late blastocyst stage (Scholer et al., 1990) . The correlation of lineage commitment with lineage-restricted transcription of formerly ubiquitously expressed transcription factors, suggests that lineage commitment may involve the repression as well as the activation of critical genes.
Despite the close association of Mash2 expression with the commitment of the trophectoderm lineage, examination of embryos mutant for Mash2 did not reveal any defect in blastocyst formation (Guillemot et al., 1994) . However, the expression of Mash2 mRNA during oogenesis suggested that both oogenetically derived and zygotically derived mRNAs could be available for translation in the early embryo. The presence of maternally derived Mash2 in oocytes derived from Mash2 heterozygotes could thus have masked the role of Mash2 in early trophoblast development. In this study we clearly show that this is not the case, since mutant embryos derived from Mash2 − / − homozygous females generated by tetraploid rescue showed no accentuated phenotype when compared with the embryos derived from heterozygous crosses. The extent of the involvement of maternal information in the development of the preimplantation mouse embryo is still largely unresolved. It is often assumed that the early onset of zygotic gene transcription, combined with the extensive degradation of maternal messages at the twocell stage, means that blastocyst formation is directed from zygotic transcripts. However, protein translated from maternal transcripts can persist during preimplantation development (West and Flockhart, 1989) and has been proposed to explain the survival beyond the blastocyst stage of a number of mutations in genes that might have been expected to be critical at earlier stages (Larue et al., 1994; Haegel et al., 1995; Riethmacher et al., 1995) . The possibility that oocyte information might be used to pattern the blastocyst is also raised by the recent demonstration of a relationship between the position of extrusion of the second polar body and the axis of the blastocyst (Gardner, 1997) . Testing for maternal involvement of gene products solely involved in generating extraembryonic lineages can be tested by the tetraploid rescue approach described here. However, the extent of involvement of specific maternally derived proteins in patterning the embryonic lineages will require oocyte-specific gene deletions, an approach that should be feasible using Cre-lox technology .
Recent studies using chimeric analysis have demonstrated that, after implantation, Mash2 function is specific to the spongiotrophoblast lineage and is not required for the formation of the giant cells or labyrinthine trophoblast cells (Tanaka et al., 1997) . The results of the current study show that Mash2 is not required for oogenesis or earlier blastocyst formation either. Thus, despite its widespread expression in the precursors of the trophectoderm and in all its diploid derivatives, Mash2 is only required in a specific time window of development and in a specific sublineage of the trophoblast. If Mash2 functions in other aspects of development of the trophoblast lineage, it must act cooperatively with other factors. One such factor may be another bHLH gene, Hxt or Hand1, which partially overlaps the Mash2 expression domain in the ectoplacental cone and spongiotrophoblast, and which has an important role in giant cell formation (Cross et al., 1995; Riley et al., 1998) . Interestingly, mutation of the orphan nuclear receptor, Errb, leads to failure of the chorionic ectoderm to develop and leads to secondary failure to maintain the spongiotrophoblast (Luo et al., 1997) , while mutation of the caudal-related gene, Cdx2, causes early postimplantation lethality, suggestive of a critical role for Cdx2 in specifying the initial formation of the trophectoderm (Chawengsaksophak et al., 1997) . Mutational analysis is thus beginning to dissect apart the hierarchy of transcription factors involved in development of the different phases of differentiation of the trophoblast lineage (Fig. 5) . Continued identification and mutation of other trophoblast-specific transcription factors should begin to elucidate the complexities of regulation of the formation and differentiation of the trophoblast lineage.
Experimental procedures
Gene expression analysis
With the exception of preimplantation gene expression studies, all studies were performed on wild-type outbred CD-1 embryos. In situ hybridization with Mash2 RNA probes was performed as previously described (Guillemot et al., 1994) on paraffin sections of female ovaries, 4.5-9.5 day embryos within the uterine decidua and later placentae dissected away from the uterus. Blastocysts were flushed from the uterus at 3.5 days of development and transferred into the ampullae of the estrus oviduct for processing.
Quantitative RT-PCR was performed on samples of androgenones, gynogenones, and normal embryos as previously described . With this method, the 3′ termini of the entire mRNA population were amplified without altering relative sequence abundance in the cDNA (Brady et al., 1990; Brady and Iscove, 1993) and then analyzed by quantitative dot blot hybridization analysis. The Mash2 probe used in these quantitative RT-PCR studies was a random-primer radiolabeled EcoRI fragment encompassing the 3′ terminus of the Mash2 coding region and part of the 3′ untranslated region. Embryos for the normal developmental series were obtained from (B6D2)F1 females mated to (B6D2)F1 males. The analysis of normal embryos included samples of germinal vesicle intact oocytes, eggs, and embryos lysed at 12 time points between the one-cell and blastocyst stages. In addition, samples were obtained during the one-and two-cell stages from embryos treated with a-amanitin, a potent inhibitor of RNA polymerase II, which permits the relative contribution of maternally inherited transcripts to the mRNA population to be evaluated. For other studies, inner cell masses were obtained as described (Solter and Knowles, 1975) . Data for the normal embryos were expressed in units of bound counts per minute (cpm) or estimated mRNA copy number as described . Nuclear transplantation to produce androgenones and gynogenones was performed as described (McGrath and Solter, 1983; Latham and Solter, 1991, 1993 ) using C57BL/6 embryos. Parthenogenetic embryos were produced by ethanol activation using eggs from either C57BL/6 or (B6D2)F1 females.
Generation and breeding of Mash2
− / − mice Viable Mash2 − / − female and male mice were generated by aggregation of tetraploid four-cell CD-1 embryos with eight-cell embryos derived from crosses between Mash2 + / − males and females, as described previously (Guillemot et al., 1994) . Three Mash2 − / − females were mated with a Mash2 + / − male. One female was sacrificed at day 3.5 of gestation to recover blastocyst stage embryos and the other two were sacrificed at day 9.5 of gestation, and the embryos examined for mutant phenotype. The remaining female was mated to a Mash2 − / − male and the pregnancy was terminated at day 10.5 of gestation.
